Metformin/atorvastatin combination therapy

· Daewoong Pharmaceutical Co. LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Metformin/atorvastatin combination therapy, covering 2023-06-18 to 2023-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) [Phase 3]